Effects of tetrandrine and fangchinoline on human platelet aggregation and thromboxane B2 formation

被引:24
|
作者
Kim, HS
Zhang, YH
Fang, LH
Yun, YP
Lee, HK
机构
[1] Chungbuk Natl Univ, Coll Pharm, Dept Pharmacol, Kaeshin Dong 361763, Cheongju, South Korea
[2] Chungbuk Natl Univ, Coll Med, Dept Pharmacol, Kaeshin Dong 361763, Cheongju, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Nat Prod Biosynth Res Unit, Taejon 305600, South Korea
关键词
fangochinoline; PAF-receptor binding; platelet aggregation; tetrandrine; thromboxane B-2;
D O I
10.1016/S0378-8741(98)00237-2
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Tetrandrine (TET) and fangchinoline (FAN) are two major components of the radix of Stephania tetrandra. The effects of TET and FAN on human platelet aggregation and formation of thromboxane (TX) B-2, a stable metabolite of TXA(2), were examined in the aspect of platelet aggregation. TET and FAN inhibited platelet-activating factor (PAF)-induced human platelet aggregation. IC50 values for TET and FAN were 28.6 +/- 3.24 mu M and 21.7 +/- 2.61 mu M, respectively. In the PAF-receptor binding assay, neither TET nor FAN showed any inhibitory effects on the specific bindings of PAF to its receptor. TET and FAN also inhibited PAF-, thrombin-: and arachidonic acid-induced thromboxane B-2 formation in human washed platelet. These results indicate that TET and FAN inhibit the platelet aggregation by interfering with the intracellular messengers system, but not by inhibiting the binding of PAF to PAF-receptor on the platelet membrane directly, and the suppression of TXA(2) formation by TET and FAN may be responsible for their inhibitory activities on the platelet aggregation and further on the thrombosis. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 50 条
  • [31] THROMBOXANE(TX)-B2 GENERATION DURING EXVIVO PLATELET-AGGREGATION - POSSIBLE OVERCOMING OF ASPIRIN EFFECT ON PLATELETS
    DECATERINA, R
    GIANNESSI, D
    GAZZETTI, P
    BERNINI, W
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 450 - 450
  • [32] SYNTHESIS OF THROMBOXANE B2
    KELLY, RC
    SCHLETTER, I
    STEIN, SJ
    TETRAHEDRON LETTERS, 1976, (37) : 3279 - 3282
  • [33] PLATELET-AGGREGATION AND THROMBOXANE-B2 FORMATION AFTER ETHANOL ABUSE - IS THERE A RELATIONSHIP TO STROKE
    HILLBOM, ME
    KANGASAHO, M
    HJELMJAGER, M
    ACTA NEUROLOGICA SCANDINAVICA, 1984, 70 (06): : 432 - 437
  • [34] SIGNIFICANCE OF PLATELET-FUNCTION AND THROMBOXANE B2 LEVELS ACROSS THE HUMAN MYOCARDIAL VASCULAR BED
    MEHTA, J
    MEHTA, P
    ACTA MEDICA SCANDINAVICA, 1981, : 111 - 121
  • [35] Ginkgo biloba extract inhibits arachidonic acid-mediated platelet aggregation aggregation and thromboxane B2 production in healthy subjects.
    Kudolo, GB
    Barrientos, J
    Elrod, R
    Wang, W
    CLINICAL CHEMISTRY, 2003, 49 (06) : A58 - A58
  • [36] A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers
    van Kraaij, DJW
    Hovestad-Witterland, AHI
    de Metz, M
    Vollaard, EJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (06) : 644 - 647
  • [37] PHENOTHIAZINE COMPOUNDS ENHANCE PHENTOLAMINE EFFECTS ON PLATELET-AGGREGATION AND THROMBOXANE-B2 PRODUCTION
    ANFOSSI, G
    TROVATI, M
    MULARONI, E
    MASSUCCO, P
    CAVALOT, F
    MATTIELLO, L
    EMANUELLI, G
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1990, 307 : 142 - 161
  • [38] Effects of tibolone on thromboxane B2 levels in postmenopausal women
    Canbaz, M
    Vural, P
    Akgül, C
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2002, 53 (01) : 13 - 15
  • [39] THROMBOXANE B2 FORMATION IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    STEFANOVIC, V
    CIRIC, V
    NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE, 1986, 17 (04): : 217 - 219
  • [40] ANTIBODIES TO PHOSPHOLIPIDS PREVENT COLLAGEN-INDUCED THROMBOXANE-B2 FORMATION AND PLATELET-AGGREGATION
    BOROWSKI, S
    TALMON, J
    MANI, A
    ZOR, U
    THROMBOSIS RESEARCH, 1986, : 78 - 78